We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Regulatory News: EGEIRO Pharma (code ISIN : BE0974387194 - mnémonique : ALVET), société biopharmaceutique spécialisée dans le repositionnement et la reformulation de médicaments existants...
Compte-rendu de l’Assemblée Générale Extraordinaire de TheraVet du 28 octobre 2024 Regulatory News: TheraVet (ISIN : BE0974387194 - ticker : ALVET), société de biotechnologie pionnière dans le...
Regulatory News: TheraVet (code ISIN : BE0974387194 - mnémonique : ALVET), société de biotechnologie spécialisée dans les traitements ostéoarticulaires en santé animale, publie le nombre...
Operation aimed at replacing TheraVet's veterinary activities with a high potential biotech program linked to the repositioning of an innovative molecule in idiopathic pulmonary fibrosis;...
Regulatory News: TheraVet (ISIN : BE0974387194 - ticker : ALVET), société de biotechnologie pionnière dans le traitement des maladies ostéoarticulaires des animaux de compagnie, annonce la...
Number of BIOCERA-VET kits sold increased by 19% compared to the 1st half of 2023, and by 72% in the 2nd quarter of 2024 compared to 2nd quarter 2023 Net sales increase by 12.1%1 compared to the...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.005 | -5.54323725055 | 0.0902 | 0.1095 | 0.0802 | 10544 | 0.09557574 | DE |
4 | -0.0388 | -31.2903225806 | 0.124 | 0.124 | 0.0802 | 6293 | 0.10390498 | DE |
12 | -0.1143 | -57.2932330827 | 0.1995 | 0.338 | 0.0802 | 31537 | 0.16418928 | DE |
26 | -0.5548 | -86.6875 | 0.64 | 0.68 | 0.0802 | 18082 | 0.21038401 | DE |
52 | -1.8148 | -95.5157894737 | 1.9 | 1.94 | 0.0802 | 12681 | 0.45407755 | DE |
156 | -6.1548 | -98.6346153846 | 6.24 | 6.46 | 0.0802 | 6594 | 1.48337783 | DE |
260 | -7.7148 | -98.9076923077 | 7.8 | 8.56 | 0.0802 | 6334 | 1.92768163 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions